Neurotech USA, Inc.
Records under this name other than the patents Neurotech USA, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,455,470 | Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,309,315 | Apparatus, method and computer program product to facilitate ordinary visual perception via an early perceptual-motor extraction of relational information from a light stimuli array to trigger an overall visual-sensory motor integration in a subject Formerly held Term ended Term ended Nov 3, 2025 · From the USPTO record | Term ended | Term ended Nov 3, 2025 | From the USPTO record |
| US 8,426,735 | Stretchable conductor and method for producing the same Formerly held Lapsed on the fee record Ended Apr 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2025 | From the USPTO record |
| US 7,371,896 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Formerly held Term ended Term ended Aug 1, 2023 · From the USPTO record | Term ended | Term ended Aug 1, 2023 | From the USPTO record |
| US 6,927,303 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Formerly held Term ended Term ended Jun 19, 2023 · From the USPTO record | Term ended | Term ended Jun 19, 2023 | From the USPTO record |
| US 7,189,878 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Formerly held Term ended Term ended Jun 19, 2023 · From the USPTO record | Term ended | Term ended Jun 19, 2023 | From the USPTO record |
| US 7,319,160 | Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same Formerly held Term ended Ended no later than Jun 19, 2023 · From the USPTO record | Term ended | Ended no later than Jun 19, 2023 | From the USPTO record |
| US 9,031,660 | Eye implant apparatus and update system for the same Lapsed on the fee record Ended May 12, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 12, 2023 | From the USPTO record |
| US 7,750,045 | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system Formerly held Term ended Term ended Apr 9, 2023 · From the USPTO record | Term ended | Term ended Apr 9, 2023 | From the USPTO record |
| US 6,644,976 | Apparatus, method and computer program product to produce or direct movements in synergic timed correlation with physiological activity Formerly held Term ended Term ended Sep 10, 2021 · From the USPTO record | Term ended | Term ended Sep 10, 2021 | From the USPTO record |